Société Française de Toxicologie
Menu icoMenu232White icoCross32White

Ajoutez un logo, un bouton, des réseaux sociaux

Cliquez pour éditer
  • Société Française de Toxicologie
  • Actualités ▴▾
    • Actualités 2025
    • Actualités 2024
    • Actualités 2023
  • La SFT ▴▾
    • Notre histoire
    • Les statuts
    • Les membres du Bureau
  • Adhérer et cotiser ▴▾
    • Adhérer à la SFT
    • Cotiser à la SFT
  • Le congrès 2025 ▴▾
    • Sponsors
    • Le programme
    • Inscriptions
    • Posters
    • Où et quand ?
    • Photos
  • Les webinaires de la SFT ▴▾
    • 2025
    • 2024
    • 2022
    • 2021
  • Autres événements ▴▾
    • 2025
    • 2026
  • Registre Européen des toxicologues (ERT) ▴▾
    • Généralités
    • 1ère demande d'inscription
    • Renouvellement d'inscription
  • Jeunes toxicologues ▴▾
    • Bourses de congrès
    • Prix de thèse
    • CFJTox
  • Cours et formation continue ▴▾
  • Offres d'emploi ▴▾
  • Archives des congrès de la SFT ▴▾
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • Et avant...
  • Se connecter
  • Actualités 2025
  • Actualités 2024
  • Actualités 2023
  • Notre histoire
  • Les statuts
  • Les membres du Bureau
  • Adhérer à la SFT
  • Cotiser à la SFT
  • Sponsors
  • Le programme
  • Inscriptions
  • Posters
  • Où et quand ?
  • Photos
  • 2025
  • 2024
  • 2022
  • 2021
  • 2025
  • 2026
  • Généralités
  • 1ère demande d'inscription
  • Renouvellement d'inscription
  • Bourses de congrès
  • Prix de thèse
  • CFJTox
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Et avant...
Retour

Unanticipated differences in the rat plasma metabolome...

Unanticipated Differences In the Rat Plasma Metabolome of Genistein and Daidzein

Gina Montoyan1, Bennard van Ravenzwaay 2, Walburga Seefelder 1, Volker Haake 3, Thomas Stroheker 1, Hennicke Kamp 3

1 Société des Produits Nestlé S.A., Lausanne, Switzerland

2 Environmental Sciences Consulting, Altrip, Germany

3 BASF Metabolome Solutions GmbH, Berlin, Germany

Genistein (GEN) and daidzein (DAI) are soy isoflavones known for their interaction with estrogen receptors, exhibiting both health benefits and concerns in humans. In this study, we conducted 28-day oral studies in male and female Wistar rats to elucidate (1) changes in metabolites, (2) compare their metabolomes with other compounds, and (3) identify toxicological modes of action (MoA).

Dose levels for GEN were 1000 and 300 mg/kg bw by gavage and 1000 and 300 ppm (via diet). DAI gavage dose levels were 1000 and 100 mg/kg bw/day. Results were evaluated using the MetaMap®Tox database. Both compounds demonstrated metabolome profiles associated with estrogenic profiles and compounds, predominantly in females. However, the metabolomes were compound-specific with relatively few common metabolite changes. Notably, there were no relevant matches between any GEN and any DAI treatment group indicating that both compounds are substantially different from metabolome perspective.

Ranking of the metabolome patterns for GEN and DAI with ≥ 1000 compounds in the MetaMap®Tox database revealed correlations with estrogenic and other hormonally active compounds. Furthermore, the metabolome of GEN-treated females correlated best with Cabergoline, a dopamine D2 receptor agonist, while DAI females with tamoxifen and diethylstilbestrol, suggesting that even their estrogenic activity may be different. Beyond estrogenic effects, the high dose (HD) DAI metabolome indicated altered fatty acid metabolism associated with PPAR-α activation, while GEN showed indications of ethanolamine-like liver effects. Dose levels without estrogenic effects for GEN were 1000 and 100 mg/kg bw/day for males and females respectively, there were no estrogenic effects in the feeding studies. For DAI, the no estrogenic effect level was 300 mg/kg bw/day for males and 100 mg/kg bw/day for females, suggesting that DAI may be a more potent estrogen than GEN in rats.

Key words: Metabolomics, Genistein, Daidzein, Estrogens

icoLinkedin35Color icoComment35Color
icoLinkedin35Color icoComment35Color
0 commentaire(s)
ou
Connectez-vous
Aucun commentaire pour le moment.
Consultez également
Container closure system of a drug-device combination product

Container closure system of a drug-device combination product

Biological evaluation and management of changes for a container closure system of a drug-device...

23 novembre 2025
iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: QSAR Predicting Thyroid Receptor Disruption

iVEMPS: A High-Accuracy QSAR Predicting Thyroid Receptor Disruption as a First Step Toward...

23 novembre 2025
COSMETICK digital tool

COSMETICK digital tool

Analysis of the toxicological profiles of cosmetic ingredients and risks for cosmetic product:...

23 novembre 2025
Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities

Effects of hepatic enzyme inducers on in vitro NIS, TPO, and DIO1-2-3 activitiesAudrey Baze1,...

23 novembre 2025
Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates

Characterization of representative plasticizer exposures in NICU neonates using non-negative...

23 novembre 2025
NAMs for evaluating DART potential

NAMs for evaluating DART potential

New approach methodologies for evaluating DART potential: Review on state of the art,...

23 novembre 2025
Hôpital Fernand-Widal - 200 rue du faubourg Saint-Denis - 75475 Paris Cedex 10 / Contact : sft.secretariat@gmail.com
icoLinkedin24Color
  • Plan du site
  • Licences
  • Mentions légales
  • CGUV
  • Paramétrer les cookies
  • Se connecter
  • Propulsé par AssoConnect, le logiciel des associations Professionnelles